Writing for Business of Cannabis, Scott Mazza, co-founder of Vitality CBD, argues that the federal spending bill provision capping finished hemp products at 0.4mg total THC per container misidentifies the problem: targeting compliant producers with USDA organic certification and years of third-party testing behind them rather than the bad actors mislabeling potency or skipping independent testing entirely. Mazza draws on Vitality CBD’s full-spectrum formulations to make the case that the proposed threshold would also eliminate science-backed products: Farm Bill 2018 research now confirms that full-spectrum extraction’s entourage effect delivers stronger therapeutic outcomes than CBD isolate, making the isolate carve-out lawmakers treat as a concession a genuine step backward. He proposes a three-part alternative — FDA oversight through the HEMP Act to remove dangerous products, a federal quality seal rewarding organic certification and transparent testing, and dosage-based rules that distinguish wellness applications from high-dose intoxicants, arguing that a sound regulatory framework for hemp must be built around the producers who have already proven they can meet the highest standards, as published in Business of Cannabis.

In this citybiz Q&A, Scott Mazza, co-founder of Vitality CBD, breaks down the federal regulatory threat facing the hemp industry: a 2025 government shutdown bill quietly replaced the “0.3% delta-9 THC by dry weight” standard with a “0.4mg total THC per container” limit, a change that would make gummies, tinctures, vapes, and most hemp extract products federally illegal and jeopardize an estimated $28 billion industry supporting 300,000 jobs. Mazza calls for a two-year extension, argues that quality-based regulation focused on mandatory testing and production standards is more effective than blanket bans, and draws a clear line between non-psychoactive CBD, backed by growing peer-reviewed research on sleep, anxiety, and pain, and recreational THC. He also addresses the quality gap in an underregulated market where nearly 60% of CBD products fail to match their stated potency, explaining the role that USDA organic certification, face-to-face partner vetting, and third-party lab testing play in Vitality CBD’s sourcing approach.

Writing for Wellbeing Magazine, Scott Mazza, co-founder of Vitality CBD, explores the therapeutic potential of CBD as a non-intoxicating intervention for neuropathy and chronic nerve pain. Mazza highlights emerging clinical research and peer-reviewed studies that demonstrate how high-quality, third-party-tested CBD can reduce pain intensity, improve sleep quality, and enhance mobility by interacting with the endocannabinoid system. Under his leadership, Vitality CBD emphasizes a holistic approach to nerve health, advocating for the use of organic, safely extracted topicals and salves to provide targeted relief for sensory discomfort.

The Vitality CBD Salve is featured in Cannabis & Tech Today’s 2026 Valentine’s Day Gift Guide as a premier choice for enhancing intimacy and shared wellness. Vitality CBD’s commitment to quality is highlighted through the product’s USDA-certified organic full-spectrum CBD, which is combined with lavender and peppermint oils to support relaxation and heightened sensation. The publication emphasizes the brand’s authority in the functional wellness space, noting the salve’s quick-absorbing, vegan formulation and rigorous third-party purity testing.

Scott Mazza, co-founder of Vitality CBD, examines the shifting federal landscape for hemp regulations and the critical need for a permanent regulatory pathway through legislation like the HEMP Act. Writing for WholeFoods Magazine, Mazza details how “total THC” framework changes and synthetic cannabinoid bans threaten industry stability, impacting over 300,000 jobs and consumer access to hemp-derived wellness. His analysis underscores Vitality CBD’s commitment to transparent FDA oversight and high-quality production standards to ensure long-term market maturity and consumer safety.

In this WholeFoods Magazine column, Scott Mazza, co-founder of Vitality CBD, argues that while peer-reviewed research increasingly supports CBD’s potential for anxiety, pain, sleep, and inflammation, inconsistent production standards continue to undermine its medical credibility. Drawing on regulatory data and industry experience, Mazza outlines how contamination, inaccurate labeling, and lack of GMP compliance prevent CBD from being taken seriously by healthcare and policymakers. He calls for nuanced, science-aligned regulation (quality standards, mandatory testing, and federal certification) rather than blanket bans, to move CBD toward evidence-based wellness adoption.

In this Wellbeing Magazine article, Scott Mazza, co-founder of Vitality CBD and Certified Headies, explains why CBD salves and topicals have emerged as one of the most durable, science-aligned applications of cannabidiol as novelty products fade. Drawing on existing research and consumer use patterns, Mazza outlines how non-ingestible CBD interacts locally with the endocannabinoid system to support pain relief, inflammation reduction, muscle relaxation, and sleep-related routines. He also stresses the importance of product quality, third-party testing, and clean formulations, noting that regulatory gaps make consumer diligence essential when applying CBD directly to the skin.

In this Nutritional Outlook analysis, Scott Mazza, co-founder of Vitality CBD, examines market data showing a decline in novelty CBD products in gas stations and convenience stores as the hemp sector matures. Mazza explains that consumers are increasingly distinguishing between wellness-focused CBD, best delivered through formats like gummies and topicals, and recreational cannabinoids such as delta-8 and THCA, which better fit convenience retail channels. He frames this shift as a positive correction driven by consumer education, science-backed applications, and demand for quality, testing, and credible producers, as published in Nutritional Outlook.

In this Cannabis & Tech Today column, Scott Mazza, co-founder of Vitality CBD, argues that the future of hemp regulation under the Farm Bill 2025 must be guided by scientific evidence rather than political reaction. Drawing on industry experience, Mazza outlines how research increasingly supports CBD’s role in areas such as anxiety, sleep, and pain management, while warning that regulatory uncertainty and state-level bans undermine consumer trust and responsible operators. He calls for nuanced, science-based federal standards, focused on testing, labeling, and access, to protect consumers without reversing the progress made since hemp legalization, as published in Cannabis & Tech Today.

In this WholeFoods Magazine column, Scott Mazza, co-founder of Vitality CBD, examines how the upcoming Farm Bill 2025 could reshape the U.S. hemp and CBD market. Mazza outlines the risks posed by unclear federal guidance, state-by-state enforcement, and proposals such as a “total THC” standard, arguing that these moves threaten responsible operators as much as bad actors. He calls for coordinated, science-based regulation, rather than product bans, to protect consumers, establish quality standards, and support CBD’s transition from novelty product to legitimate wellness category, as published in WholeFoods Magazine.

In this Wellbeing Magazine article, Scott Mazza, co-founder of Vitality CBD and Certified Headies, explains how THCA differs from THC, why it is non-intoxicating in its raw form, and how heat-driven conversion creates both its psychoactive potential and legal complexity. Mazza details how THCA remains legal in the U.S. under the 2018 Farm Bill and in the U.K. due to its exclusion from controlled substance listings, while noting that proposed “total THC” standards could significantly alter its status. He emphasizes the need for clear, science-based regulation and consumer diligence, highlighting the importance of third-party testing and quality standards in an underregulated market.

In this candid review, industry influencer Chillydilly evaluates the Vitality Delta 8 Super Lemon Haze cartridge, specifically praising its “super clean” flavor profile and smooth vapor quality. With years of experience reviewing hemp derivatives, Chillydilly highlights the product as a reliable, manageable alternative for users seeking a clear-headed body high without the overwhelming psychoactivity of traditional flower.